Anatara Lifesciences Ltd (AU:ANR) has released an update.
Anatara Lifesciences Ltd, listed as ANR on the ASX, is dedicated to developing innovative health solutions targeting the gastrointestinal tract and associated medical conditions. The company aims to grow its product pipeline through internal development and strategic partnerships, focusing on delivering real benefits to patients and value to shareholders.
For further insights into AU:ANR stock, check out TipRanks’ Stock Analysis page.